SGK1 and neoplasm: Surprisingly, intraperitoneal injection of GSK-650394 (MCE, China) before modeling resulted in the reduction of CRLM tumor burden in mice, compared with the group of mice with a specific knockout of hepatocytes SGK1 (Additional file 2: Fig. S6A, B).